Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications

Hypertension

Volumn 59, Issue 3, 2012, Pages 621-626

  Lee, Hae Ahm ^a   Cho, Hyun Min ^a   Lee, Dong Youb ^a   Kim, Kee Chul ^a   Han, Hyung Soo ^a   Kim, In Kyeom ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

ACE1; chromatin remodeling; epigenetic; hypertension; SHR

Indexed keywords

BISULFITE; DIPEPTIDYL CARBOXYPEPTIDASE; HISTONE H3; LYSINE; MESSENGER RNA; VALSARTAN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; EPIGENETICS; ESSENTIAL HYPERTENSION; GENE EXPRESSION; HEART; HISTONE ACETYLATION; HISTONE CODE; HISTONE MODIFICATION; KIDNEY; LIVER; LUNG; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADRENAL GLANDS; ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HISTONE CODE; HYPERTENSION; KIDNEY; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; UP-REGULATION;

EID: 84862808878     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.182428     Document Type: Article

References (32)

1. Lavoie JL, Sigmund CD. Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system. Endocrinology. 2003;144: 2179-2183. (Pubitemid 36629863)
2. Dendorfer A, Dominiak P, Schunkert H. ACE inhibitors and angiotensin II receptor antagonists. Handb Exp Pharmacol. 2005;407-442.
3. Chappell MC. Emerging evidence for a functional angiotensin-converting enzyme 2-angiotensin-(1-7)-mas receptor axis: more than regulation of blood pressure? Hypertension. 2007;50:596-599. (Pubitemid 47442717)
4. Bernstein KE, Shen XZ, Gonzalez-Villalobos RA, Billet S, Okwan-Duodu D, Ong FS, Fuchs S. Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE). Curr Opin Pharmacol. 2011;11:105-111.
5. Kumar RS, Thekkumkara TJ, Sen GC. The mRNAs encoding the two angiotensin-converting isozymes are transcribed from the same gene by a tissue-specific choice of alternative transcription initiation sites. J Biol Chem. 1991;266:3854-3862. (Pubitemid 21909288)
6. Ronchi FA, Andrade MC, Carmona AK, Krieger JE, Casarini DE. N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hypertensive rats. J Hypertens. 2005;23: 1869-1878. (Pubitemid 41830427)
7. Bueno V, Palos M, Ronchi FA, Andrade MC, Ginoza M, Casarini DE. N-domain angiotensin I-converting enzyme expression in renal artery of Wistar, Wistar Kyoto, and spontaneously hypertensive rats. Transplant Proc. 2004;36:1001-1003. (Pubitemid 38766254)
8. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P, Alhenc-Gelas F. The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett. 1989; 252:99-104. (Pubitemid 19201083)
9. Wilcox CS, Dzau VJ. Effect of captopril on the release of the components of the renin-angiotensin system into plasma and lymph. J Am Soc Nephrol. 1992;2:1241-1250.
10. Casarini DE, Plavinik FL, Zanella MT, Marson O, Krieger JE, Hirata IY, Stella RC. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int J Biochem Cell Biol. 2001; 33:75-85. (Pubitemid 32146469)
11. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M. The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol. 2001;88:1L-20L. (Pubitemid 33022712)
12. Shiota N, Miyazaki M, Okunishi H. Increase of angiotensin converting enzyme gene expression in the hypertensive aorta. Hypertension. 1992; 20:168-174.
13. Sharifi AM, Akbarloo N, Heshmatian B, Ziai A. Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. Pharmacol Res. 2003;47:201-209. (Pubitemid 36259922)
14. Lee J. Reciprocal regulation of angiotensin converting enzyme and neutral endopeptidase in rats with experimental hypertension. Physiol Res. 2004;53:365-368. (Pubitemid 39094823)
15. Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD. Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci. 2010;17:227-238.
16. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension. 2002;40:827-833. (Pubitemid 35434902)
17. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Inagami T. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens. 2000;18:1247-1255.
18. Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ, Xia CY, Liu JG, Su DF. Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res. 2008; 58:196-201.
19. Song R, Van Buren T, Yosypiv IV. Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis. Pediatr Res. 2010;67:573-578.
20. Karpha M, Lip GV. The pathophysiology of target organ damage in hypertension. Minerva Cardioangiol. 2006;54:417-429. (Pubitemid 44689838)
21. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ. Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res. 2007;100:520-526. (Pubitemid 46673261)
22. Riviere G, Lienhard D, Andrieu T, Vieau D, Frey BM, Frey FJ. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics. 2011;6:478-489.
23. Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F, Turner BM. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem. 2007;282:4408-4416. (Pubitemid 47100929)
24. Mohan M, Lin C, Guest E, Shilatifard A. Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis. Nat Rev Cancer. 2010;10:721-728.
25. Hazzalin CA, Mahadevan LC. Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun. PLoS Biol. 2005;3:e393.
26. Wei CC, Hase N, Inoue Y, Bradley EW, Yahiro E, Li M, Naqvi N, Powell PC, Shi K, Takahashi Y, Saku K, Urata H, Dell'italia LJ, Husain A. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest. 2010;120:1229-1239.
27. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, Rappsilber J, Hansen KH, Salcini AE, Helin K. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007;128:1063-1076. (Pubitemid 46427869)
28. Geiman TM, Sankpal UT, Robertson AK, Zhao Y, Robertson KD. DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Biochem Biophys Res Commun. 2004;318:544-555. (Pubitemid 38553814)
29. Goto M, Hoxha N, Osman R, Wen J, Wells RG, Dell KM. Renin-angiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr. 2010;50:639-644.
30. Prasad A, Narayanan S, Husain S, Padder F, Waclawiw M, Epstein N, Quyyumi AA. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition. Circulation. 2000;102:35-41. (Pubitemid 30430550)
31. Johnson AD, Gong Y, Wang D, Langaee TY, Shin J, Cooper-Dehoff RM, Schork NJ, Binkley P, Pepine CJ, Johnson JA, Sadee W. Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension. Clin Pharmacol Ther. 2009;85: 36-44.
32. Chu CH, Lo JF, Hu WS, Lu RB, Chang MH, Tsai FJ, Tsai CH, Weng YS, Tzang BS, Huang CY. Histone acetylation is essential for ANG-IIinduced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart. J Cell Physiol. 2012;227:259-268.